RIFABUTIN

作品数:9被引量:65H指数:3
导出分析报告
相关领域:医药卫生更多>>
相关作者:王雪孙怡高承英任爽李朝旭更多>>
相关机构:首都医科大学北京协和医学院更多>>
相关期刊:《国外新药介绍》《World Journal of Gastroenterology》《Asian Pacific Journal of Tropical Medicine》《中国临床药理学与治疗学》更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-9
视图:
排序:
Rifabutin as salvage therapy for Helicobacter pylori eradication:Cornerstones and novelties
《World Journal of Gastroenterology》2022年第45期6356-6362,共7页Antonia Valeria Borraccino Francesca Celiberto Maria Pricci Bruna Girardi Andrea Iannone Maria Rendina Enzo Ierardi Alfredo Di Leo Giuseppe Losurdo 
When several Helicobacter pylori eradication treatments fail,guidelines recommend a cultured guided approach;however,culture is not widely available.Therefore,a rifabutin based regimen could be the best solution.Rifab...
关键词:Helicobacter pylori ERADICATION RIFABUTIN Antibiotic resistance Rescue therapy TREATMENT 
Rifabutin reduces systemic exposure of an antimalarial drug 97/78 upon co-administration in rats:an in-vivo & in-vitro analysis
《Asian Pacific Journal of Tropical Medicine》2015年第8期620-625,共6页Yeshwant Singh Mahendra Kumar Hidau Shio Kumar Singh 
the Council for Scientific and Industrial Research (CSIR),India,for providing research fellowships
Objective: To determine the potential drug-drug interactions between anti-malarial candidate 97/78 and anti-tubercular drug rifabutin in-vivo in rats followed by in-vitro investigation of the underlying mechanisms of ...
关键词:Accumulation Relative BIOAVAILABILITY SEX effect PHARMACOKINETICS 
Second and third line treatment options for Helicobacter pylori eradication被引量:7
《World Journal of Gastroenterology》2014年第6期1517-1528,共12页Mingjun Song Tiing Leong Ang 
Helicobacter pylori is a highly successful bacterium with a high global prevalence and the infection carries significant disease burden. It is also becoming increasingly difficult to eradicate and the main reason for ...
关键词:Helicobacter pylori Treatment failure Salvage therapy Drug resistance Microbial Bismuth OFLOXACIN MOXIFLOXACIN METRONIDAZOLE RIFABUTIN RIFAXIMIN SITAFLOXACIN 
“Rescue” regimens after Helicobacter pylori treatment failure被引量:21
《World Journal of Gastroenterology》2008年第35期5385-5402,共18页Javier P Gisbert 
The Instituto de Salud Carlos Ⅲ
Helicobacter pylori (H pylori) infection is the main cause of gastritis, gastroduodenal ulcer disease, and gastric cancer. After more than 20 years of experience in H pylori treatment, in my opinion, the ideal regimen...
关键词:Helicobacter pylori RESCUE SALVAGE RIFABUTIN LEVOFLOXACIN 
Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn’s disease被引量:2
《World Journal of Gastroenterology》2008年第17期2723-2730,共8页Daniel R Beckler Sammer Elwasila George Ghobrial John F Valentine Saleh A Naser 
Supported by Grant RO1-AI51251-01 from NIH-NIAID
AIM: To investigate overlapping regions of the rpoB gene previously involved with rifamycin resistance in M. tuberculosis and seek correlation between rpoB mutations in dinical MAP strains with susceptibility to RIF ...
关键词:Mycobacterium paratuberculosis Crohn's disease RIFABUTIN RIFAMPICIN RPOB Minimum inhibitoryconcentration 
Third-line rescue therapy for Helicobacter pylori infection被引量:31
《World Journal of Gastroenterology》2006年第15期2313-2319,共7页Rossella Cianci Massimo Montalto Franco Pandolfi Giovan Battista Gasbarrini Giovanni Cammarota 
H pylori gastric infection is one of the most prevalent infectious diseases worldwide. The discovery that most upper gastrointestinal diseases are related to Hpylori infection and therefore can be treated with antibio...
关键词:Helicobacter pylori Third-line rescue therapy Antimicrobial resistance LEVOFLOXACIN RIFABUTIN FURAZOLIDONE DOXYCYCLINE 
利福霉素衍生物Rifabutin的临床药理研究进展被引量:4
《中国临床药理学与治疗学》2006年第1期1-9,共9页李朝旭 张锦楠 任爽 高承英 孙怡 王雪 
北京市教委科研基金资助项目(№KM200410025007)
Rifabutin(RBT)是一种类似于利福平(RIF)的利福霉素衍生物。1992年被美国FDA批准用于治疗和预防发生在AIDS患者上的鸟分枝杆菌(MAC)感染,随后许多国家相继批准使用该药。但是后来RBT已不仅被用于预防治疗MAC,还用于治疗肺结核以及幽门...
关键词:RIFABUTIN CYP450 药物相互作用 MAC 肺结核 HELICOBACTER PYLORI 
用Rifabutin治疗近期诊断的肺结核:该药对利福平的多国随机比较性研究被引量:1
《国际结核病与肺部疾病杂志》1996年第3期99-106,共8页L.J.Gonzalez-Montaner S.Natal P.Yongchaiyud P.Olliaro the Rifabutin Study Group 李荣德 
背景:在阿根廷、巴西、泰国的6个中心征集到的新近诊断、对药物敏感、X线片活动、经细菌学证实的肺结核病人。目标:评价两个含有不同每日剂量的rifabufin的用药方案与利福平的功效、耐受性和毒性的比较。设计:多中心、随机、比较性研究...
关键词:比较性研究 不良反应 细菌学 追踪观察 耐受性 治疗方案 药物敏感 利福平 成功率 泰国 
抗菌剂Rifabutin
《国外新药介绍》1994年第2期17-18,共2页
关键词:抗菌素 RIFABUTIN 艾滋病 肺结核 
检索报告 对象比较 聚类工具 使用帮助 返回顶部